It might seem like a small detail, but it marks a serious blow to the push for ‘divergence’.

Anthony Robinson presents a panoramic view of the current travails defining a post-Brexit nation.

The UK government has announced an indefinite extension to the use of CE marking for British businesses, which shows that products meet EU standards. This is a major U-turn from the previous plan to introduce a UKCA system, which would have created costly duplication and reduced consumer choice. The UKCA system was an absurd consequence of Brexit...

Are you a quality manager for a small medical device start-up looking to expand into global markets? Or maybe you are a seasoned device manufacturer preparing to once again traverse quality regulations to deliver a new product to the European market?

For new medical devices entering the UK market, they will only need to comply with the old, and for some, less stringent, device standard (MDR, 2002). / ... Coupled with the additional authorisation process required to reach the UK market, this may lead to delays or deter companies from selling their products in the UK altogether.

Continuing the letter to Jacob Rees-Mogg, reminding him – he seems to need reminding – of the many new opportunities created by Brexit.

Medical devices illustrate the limited scope for post-Brexit UK divergence from EU rules, and the trade-offs the UK must face. / 'Many manufacturers have suggested they will not bother with the additional cost and complexity of putting their devices through the UKCA processes on top of the updated European process.'

PSA Part’s Sales Director, Nick Walsh looks at how Brexit is impacting cross European border trade for the tech channel and how companies can look to address these challenges.